SuperworthImmucell market cap ICCC
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $93.1M
- Highest close in our data
- $101.4M
- Jul 2026
Immucell is worth $93.1M at the close on Oct 23, 2026, at $10.25 a share.
That is up 69% over the last year and up 37% over five years.
Its highest close in our data was $101.4M in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $93.1M | $53.6M | $101.4M | +68% |
| 2025 | $55.4M | $42.3M | $68.7M | +25% |
| 2024 | $44.4M | $27.7M | $44.4M | +12% |
| 2023 | $39.5M | $34.7M | $57.9M | −17% |
| 2022 | $47.3M | $47.3M | $77.9M | −24% |
| 2021 | $61.9M | $44.9M | $85.7M | +44% |
| 2020 | $42.9M | $28.8M | $45.1M | +21% |
| 2019 | $35.3M | $33M | $49.5M | −10% |
| 2018 | $39.4M | $35.4M | $49.3M | −11% |
| 2017 | $44.4M | $25.8M | $46.6M | +54% |
| 2016 | $28.8M | $17.9M | $33.9M | +25% |
| 2015 | $23M | $15.4M | $33.3M | +58% |
| 2014 | $14.6M | $10.4M | $16.2M | +18% |
| 2013 | $12.4M | $9.9M | $14.2M | +6% |
| 2012 | $11.7M | $11.4M | $20.2M | −16% |
| 2011 | $14M | $13.6M | $19.6M | n/a |
Against its peers
Companies in Healthcare nearest Immucell's size, closest first, today.
| Company | Market cap |
|---|---|
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| APTAlpha Pro Tech | $56.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| NEPHNephros | $38.3M |
| Peer median | $84.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Immucell
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.